MicroIslet Holds Positive Pre-IND Meeting for US Based Human Clinical Trial With FDA (Business Wire via Yahoo! Finance)
SAN DIEGO----MicroIslet, Inc. , a biotechnology company engaged in the development and commercialization of transplantation therapies for diabetes, announced that it has met with the U.S.

Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA (Business Wire via Yahoo! Finance)
FORT LEE, N.J.----Neurologix, Inc. , a biotech company engaged in the research and development of innovative gene therapies for the brain and central nervous system, announced today that the U.S.